Article
[Mutation testing for non-small-cell lung cancer].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke - 30 Apr 2012
Brustugun Odd Terje, Helland Åslaug, Fjellbirkeland Lars, Kleinberg Lilach, Ariansen Sarah, Jebsen Peter, Scott Helge, Dønnem Tom, Bremnes Roy, Berg Thomas, Grønberg Bjørn Henning, Dai Hong Yan, Wahl Sissel Gyrid Freim, Mangseth Kjersti, Helgeland Lars
Abstract excerpt
BACKGROUND: Epidermal growth-factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKI) are a relatively new class of drugs for treatment of non-small-cell lung cancer. The national professional group for lung cancer, The Norwegian Lung Cancer Group, recommends that patients with non-small-cell lung cancer are tested for mutations in the EGFR gene. Here, we report the experience collected after the introduction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.